Weis Markets reported third quarter 2026 revenue of $1.28 billion, a 3.0% increase year-over-year that slightly exceeded analyst expectations. However, earnings per share of $0.90 missed the $1.15 estimate by 21.7%. Comparable store sales excluding fuel declined 1.2%, falling short of the projected 2.1% growth, as the company navigated pharmacy pricing headwinds and temporary supply chain issues.
Key Highlights
- Comparable store sales excluding fuel decreased 1.2%, significantly underperforming analyst expectations of a 2.1% increase.
- Pharmacy revenue was negatively impacted by $14.56 million due to Inflation Reduction Act pricing changes, which reduced total revenue growth by 1.2 percentage points.
- Gross profit margin expanded to 25.5% from 24.8% in the prior year, driven by improved inventory shrink performance and internal supply chain efficiencies.